Beijing SL Pharmaceutical (002038.SZ) Earnings Analysis
Beijing SL Pharmaceutical (002038.SZ) has no confirmed upcoming earnings date. Trailing P/E -12.02.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 002038.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 002038.SZ. This page updates as the calendar is published.
002038.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-06-30 | 0.06533 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.04 CNY | n/a | n/a | n/a |
| 2024-12-31 | -0.05195 CNY | n/a | n/a | n/a |
| 2024-09-29 | -0.04509 CNY | n/a | n/a | n/a |
002038.SZ valuation and analyst view
| Trailing P/E | -12.02 |
|---|---|
| Trailing EPS | -0.44525 CNY |
| Price / book | 1.18 |
| Dividend yield | 0.18% |
| Market cap | 5.70B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Beijing SL Pharmaceutical (002038.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 002038.SZ. This page updates as the calendar is published.
Did 002038.SZ beat earnings last quarter?
Consensus estimate data was not available for 002038.SZ's 2025-06-30 report.
What is 002038.SZ's current P/E ratio and EPS?
002038.SZ trades at a trailing P/E of -12.02 on trailing EPS of -0.4452499695389065 CNY.
What do analysts rate 002038.SZ?
002038.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.